Rachel Labell

Title: Rachel Labell: Innovator in Pharmaceutical Formulations

Introduction

Rachel Labell is a prominent inventor based in Greenville, NC (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative methods and kits for improved stability of active ingredients.

Latest Patents

Rachel holds a patent for her work titled "Formulations, methods, kits, and dosage forms." This patent focuses on formulations that comprise at least two active ingredients, specifically AMD3100, a stem cell mobilizer, and Tacrolimus, a derivative or analog of FK506. The formulations are designed to be administered as a single dose subcutaneous injection and may be beneficial in treating various diseases, disorders, or injuries. She has 1 patent to her name.

Career Highlights

Rachel is currently associated with Medregen, LLC, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving patient outcomes through advanced formulations.

Collaborations

Rachel collaborates with talented individuals such as Zhaoli Sun and John Sun, contributing to a dynamic team focused on groundbreaking research and development.

Conclusion

Rachel Labell's contributions to pharmaceutical formulations exemplify her dedication to innovation in medicine. Her work not only enhances the stability of critical medications but also holds promise for improving treatment options for patients.